公司资料
Bolt Biotherapeutics 股价、新闻与催化剂
- 股票代码:
- BOLT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.20 USD (-4.48%)
收盘价
最后更新: 2026年8月17日
9.82M USD
市值
股价为何变动
As of Aug 17, 2026, BOLT closed down 4.48% at $3.20. No new same-company headline was identified in the current news window.
公司概览
Immune-Stimulating Antibody Conjugates
Bolt Biotherapeutics develops Boltbody immune-stimulating antibody conjugates that combine tumor targeting with activation of innate and adaptive immunity.
BDC-4182
BDC-4182 targets claudin 18.2 and is being evaluated in gastric, gastroesophageal junction, pancreatic, and other solid tumors.
Mechanistic Positioning
The program is designed to combine antibody-drug conjugate-like precision with durable immune activation associated with T-cell-engaging therapies.
未来催化剂
- Initial Phase 1/2 BDC-4182 clinical data in gastric and gastroesophageal cancers are expected in the third quarter of 2026.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。